Debt to Equity Ratio Chart

View Debt to Equity Ratio for NXGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 1.507
March 31, 2026 1.073
December 31, 2025 0.6925
September 30, 2025 0.6155
June 30, 2025 0.5684
March 31, 2025 0.5264
December 31, 2024 0.4911
September 30, 2024 0.6951
June 30, 2024 0.7187
March 31, 2024 0.6416
December 31, 2023 0.5957
September 30, 2023 0.4168
June 30, 2023 0.3771
March 31, 2023 0.3472
December 31, 2022 0.2728
September 30, 2022 0.2582
Date Value
June 30, 2022 0.3634
March 31, 2022 0.2996
December 31, 2021 0.3528
September 30, 2021 7.337
June 30, 2021 10.91
March 31, 2021 1.408
December 31, 2020 17.99
September 30, 2020 3.329
June 30, 2020 2.878
March 31, 2020 1.601
December 31, 2019 2.413
September 30, 2019 5.016
June 30, 2019
March 31, 2019
December 31, 2018 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Abbott Laboratories 0.638
Align Technology, Inc. 0.0286
AngioDynamics, Inc. 0.0641
Accuray, Inc. 4.502
Alphatec Holdings, Inc. 52.37